Fundraising FoxVanedge Capital Limited Partnership — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
RoosterBio supplies human mesenchymal stem/stromal cells (hMSCs), exosome systems, and cGMP media with built-in processes and protocols for companies and researchers developing cell therapy, gene therapy, and tissue engineering products.
Advanced ManufacturingBiotechMedical DevicesFrederick, US
Jon Rowley(Director)inTimothy Kelly(Executive Officer, Director)Margot Connor(Executive Officer, Director)Uplaksh Kumar(Chief Operating Officer)
BoardMartin Westberg(Director)Rob Carlson(Director)
Co-investorsDynamk CapitalMaryland TEDCOTEDCOVanedge CapitalAvant Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.